Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12613000258752
Ethics application status
Approved
Date submitted
4/03/2013
Date registered
5/03/2013
Date last updated
27/07/2018
Type of registration
Prospectively registered

Titles & IDs
Public title
Rural patients with Inflammatory Bowel Disease (IBD) – burden of disease and perceived barriers to treatment.
Scientific title
In rural patients with Inflammatory Bowel Disease (IBD) what is the burden of disease and how does this compare with their urban counterparts.
Secondary ID [1] 282051 0
nil known
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Inflammatory Bowel Disease 288525 0
Condition category
Condition code
Oral and Gastrointestinal 288856 288856 0 0
Inflammatory bowel disease
Public Health 288887 288887 0 0
Health service research

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
The study will look at the burden of disease/health outcomes of rural patients with IBD and be compared with metropolitan patients with IBD. The health outcomes will be gathered through a once off questionnaire.

Rural care providers will be surveyed with a separate questionnaire (once off) to obtain information regarding their IBD practice, IBD knowledge and perceived barriers to care of their IBD patients.

Once both groups have been surveyed (after enrollment in study) they will not be contacted again.
Intervention code [1] 286643 0
Not applicable
Comparator / control treatment
Control group - metropolitan patients with IBD. This cohort will not be contacted as information regarding their health outcomes has previously been collected

Medical Records data for suitable patients from 2002-2012
Control group
Historical

Outcomes
Primary outcome [1] 288984 0
Disease burden/IBD health outcomes of rural IBD patients will be assessed through a once off questionnaire.
Timepoint [1] 288984 0
1 questionnaire at the beginning of the study period. (ie as soon as the participant has consented to the study).
Secondary outcome [1] 301500 0
Data relating to rural doctor's (GP/Surgeon/physician) IBD practice, IBD knowledge and perceived barriers to the care of their IBD patients through a once off questionnaire.
Timepoint [1] 301500 0
1 questionnaire at the beginning of the study period. (ie as soon as the participant has consented to the study).

Eligibility
Key inclusion criteria
1. Patients
- Residing in rural location
- diagnosis of IBD

2. Doctors
- practicing in rural location
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
<18 years

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Stopped early
Data analysis
Data analysis is complete
Reason for early stopping/withdrawal
Participant recruitment difficulties
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA
Recruitment postcode(s) [1] 6448 0
5290 - Mount Gambier

Funding & Sponsors
Funding source category [1] 286824 0
Commercial sector/Industry
Name [1] 286824 0
Janssen
Country [1] 286824 0
Australia
Primary sponsor type
Government body
Name
SA Department of Health
Address
Citi Centre Building 11 Hindmarsh Square Adelaide South Australia 5000

Postal address: PO Box 287 Rundle Mall Adelaide SA 5000
Country
Australia
Secondary sponsor category [1] 285614 0
None
Name [1] 285614 0
Address [1] 285614 0
Country [1] 285614 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 288890 0
Southern Adelaide Clinical Human Research Ethics Committee
Ethics committee address [1] 288890 0
Ethics committee country [1] 288890 0
Date submitted for ethics approval [1] 288890 0
Approval date [1] 288890 0
09/01/2013
Ethics approval number [1] 288890 0
365a.12

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes
Attachments [1] 2917 2917 0 0
/AnzctrAttachments/363796-HSPR-2-18.pdf (Publication)

Contacts
Principal investigator
Name 38242 0
Dr Alice Bennett
Address 38242 0
Department of Gastroenterology
Flinders Medical Centre
Flinders Drive
Bedford Park SA
5042
Country 38242 0
Australia
Phone 38242 0
+61 4 288 30 979
Fax 38242 0
Email 38242 0
alice.bennett@health.sa.gov.au
Contact person for public queries
Name 38243 0
Alice Bennett
Address 38243 0
Department of Gastroenterology
Flinders Medical Centre
Flinders Drive
Bedford Park SA
5042
Country 38243 0
Australia
Phone 38243 0
+61 8 8204 4964
Fax 38243 0
Email 38243 0
alice.bennett@health.sa.gov.au
Contact person for scientific queries
Name 38244 0
Alice Bennett
Address 38244 0
Department of Gastroenterology
Flinders Medical Centre
Flinders Drive
Bedford Park SA
5042
Country 38244 0
Australia
Phone 38244 0
+61 8 8204 4964
Fax 38244 0
Email 38244 0
alice.bennett@health.sa.gov.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.